Depletion of peritoneal CD5+ B cells has no effect on the course of Leishmania major infection in susceptible and resistant mice

Clinical and Experimental Immunology

Volumn 117, Issue 1, 1999, Pages 123-129

  Babai, B ^a   Louzir, Hechrni ^a   Cazenave, P A ^b   Dellagi, K ^a  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b INSTITUT PASTEUR   (France)

Author keywords

CD5+ B cells; Experimental leishmaniasis; Leishmania major

Indexed keywords

CD5 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HOST RESISTANCE; HOST SUSCEPTIBILITY; IMMUNE STATUS; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LEISHMANIA MAJOR; LEISHMANIASIS; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACTINS; ANIMALS; ANTIGENS, CD5; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; IMMUNOGLOBULIN G; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERLEUKIN-10; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PERITONEAL CAVITY; T-LYMPHOCYTE SUBSETS;

EID: 0032972231     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00953.x     Document Type: Article

References (46)

1. Müller I. Garcia-Sanz J, Titus R, Behin R, Louis J. Analysis of the cellular parameters of the immune responses contributing to resistance and susceptibility of mice to infection with the intracellular parasite Leishmania major. Immunol Rev 1989; 112:95-113.
2. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13:151-77.
3. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon-gamma or interleukin-4 during the resolution of progression of murine leishmniasis: Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989; 169:59-72,
4. + subsets during murine Lelshmania major infection. Res Immunol 1991; 142:28-32.
5. Belosevic M, Finbloom DS, Van Der Meide PH. Administration of monoclonal anti-IFN-gamma antibodies in vivo Abrogates natural resistane of C3H/HeN mice to infection with Leishmania major, J Immunol 1989; 143:26-74.
6. Chutelain R, Varkila K, Coffman RL. IL-4 induces a Th2 response in Leishmania major-infected mice. J Immunol 1992; 148:1182-7.
7. Launois P, Swihart KG, Milon G, Louis JA. Early production of IL-4 in susceptible mice infected with Leishmania major rapidly induces IL-12 unresponsiveness. J Immunol 1997; 158:3717-24.
8. Howard JO, Liew FY, Hale C, Nicklin S. Prophylactic immunization against experimental leishmaniasis. II Further characterization of the protective immunity against fatal Leshmania tropica infection induced by irradiated promastigotes. J Immunol 1984; 132:450-5.
9. Sacks DL, Scott PA, Asofsky R, Sher A. Cutaneous leishmaniasis in anti-IgM-treated mice: Enhanced resistance due to functional depletion of a B cell-dependent T-cell involved in the suppressor pathway. J Immunol 1984; 132:2072-7.
10. Scott P, Natovitz P, Sher A, B lymphocytes are required for the generation of T cells that mediate healing uf cutaneous leishmaniasis. J Immunol 1986; 137:1017-21.
11. Titus RG, Muller I, Kimsey P, Cemy A, Behin R, Zinkernagel RM, Louis IA, Exacerbation of experimental murine cutaneous leishmaniasis with CD4 Leishmanla major-specific T cell lines or clones which secrete interferon-gamma and mediate parasite-specific delayed type hypersensitivity. Eur J Immunol 1991; 21:559-67.
12. O'Garra A, Chang R, Go N, Hastings R, Haughton G, Howard M. T.y-1 B (B-1) cells are the main source of B cell-derived IL-10. Eur J Immunol 1992; 22:711-7.
13. Herzenberg LA. Stall AM, Lalor PA, Sidman C, Moore WA, Parks DR. The Ly-1 B cell lineage. Immunol Rev 1986; 93:81-102.
14. Hardy RR, Hayakawa K. CD5 B cells, a fetal B cell lineage. Adv Immunol Rev 1994; 55:297-339.
15. Avrameas S, Guilbert B, Dighiero G. Natural antibodies against tubulin, actin, myoglobin, thyroglobulin, fetuin, albumin, and transferrin are present in normal human sera and monoclonal immunoglobulins from multiple myeloma and Waldenström's macroglobulinemia may express similar antibody specificities. Ann Immunol (Inst Pasteur) 1981; 132e:231-6.
16. Hayakawa K, Ilardy R, Parks DR, Herzenberg LA, Steinberg AD, Herzenberg LA. Ly-1 B cells: Functionally distinct lymphocytcs that secrete IgM autoantibodies, Proc Natl Acad Sci USA 1984; 81:2494-8.
17. Dighiero G, Lymberi P, Holmberg D, Lundquist I, Coutinho A, Avrameas M. High frequency of natural autoantibodies in normal newborn mice. J Immunol 1985; 134:765-71.
18. + B cell subset, Science 1987; 236:77-81.
19. + B lymphocytes as cells making antibodies binding multiple self and exogenous molecules. Int Rev Immunol 1988; 3:17-45.
20. Ishida H, Hastings R, Keamey J, Fattah D, Thorbecke GJ. Continuous anti-interleukin 10 antibody administration depletes mice of Ly-1 B cells httl not conventional B cells. J Exp Mad 1992; 175:1213-20.
21. + B cells in patients with Mediterranean visceral leishmaniasis. Clin Exp Immunol 1994; 95:479-84.
22. Taylor-Robinson AW, Phillips RS. B cells are required for the switch from Th1- to Th2-regulated immune renponses to Plasmodium chabaudi chabaudi infection. Infect Immun 1994; 62:2490-8.
23. Taylor-Robinson AW. Phillips RS, Reconstitution of B cell-depleted mice ith B cells restores Th2-type immune responses during Plasmodium chabaudi Chabaudi infection. Infect Immun 1996; 64:366-70.
24. Minoprio P, Coutinho. A. Spinella SH, Joskowicz M. Xid immunodeficiency imparts increased parasite clearance and resistance to pathology in experimental Chagas' disease. Int Immunol 1991; 3:427-33.
25. + T cell subsets. Proc Natl Acid Sci USA 1994; 91:18-22.
26. Palanivel V, Posey C, Horauf AM, Solbach W. Piessens WF, Harn DA. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain purasitic diseases. Exp Parasitol 1996; 84:168-77.
27. + B220′) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol 1997; 158:338-44.
28. Gieni RS, Trinchieri G, Umetsu DT, Dekruyff RH. Differential regulation of IL-10 synthesis: B cells from BALB/e hut not C57BL/6 mice produce IL-10. Proceedings of the 9th International Congress of Immunology (Abstr.) 1995.
29. Mosmann TR, Coffman RL, Th1 and Th2 cells: Different patterns of lymphokine secretion leads to different functional properties. Annu Rev Immunol 1989; 7:145-73.
30. Hoerauf A, Solbach W, Lohoff M, Röllinghoff M. The Xid defect determines an improved clinical course of murine leishmaniasis in susceptible mice. Int Immunol 1994; 6:1117-24.
31. Rawlings DJ, Saffran DC, Tsukada S et al. Maturation unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 1993; 261:358-61.
32. Huyakuwa K, Hardy R, Parks DR, Herxenberg LA. The 'Ly-1 B' cell subpopulation in normal, Immunodeficient, and untoimmune mice. J Exp Med 1983; 157:202-18.
33. Minoprio P, El Chelkh MC, Murphy E, Hontebeyrie-Joskowicz M, Coffman R, Coutinho A, O'Garra A. Xid-associated resistance to experimental Chagas' disease in IFN-γ-dcpendent, J Immunol 1993; 151:4200-8,
34. Cazenave P-A, Martinez-AC, Coutinho A, Differential L chain expression in the antibody response to phosphorylcholine of adult bone marrow or peritoneum-derived B lymphocytes. J Immunol 1989; 142:8-11.
35. Weintraub J, Weibbaum FI. The effect of BCG on experimental cutaneous leishmaniasis in mice. J Immunol 1977; 188:288-90.
36. Melby PC, Neva FA, Sacks DL. Profile of human T cell renponse to leishmanial antigens: Analysis by immunobloting. J Clin Invest 1989; 83:1868-75.
37. Titus RG, Marchand M, Boon T, Louis JA. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 1985; 7:545-55.
38. Spudish JA, Walt S. The regulation of rabbit skeletal muscle concentration. J Biol Chem 1971; 246:4866-9.
39. Liew FY, O'Donnell CA. Immunology of leishmaniansis. Adv Parasitol 1993; 32:161-259.
40. Murray HW. Interferon-gamma and host anitimicrobial defense: Current and future clinical applications. Am J Med 1994; 97:459-67.
41. Gazzinelli RT, Oswald IP, James SL, Sher A. IL-10 inhibits parasite killing and nitric oxide production by IFN-γ-activated macrophages. J Immunol 1992; 148:1792-6.
42. + T cells through IL-12 produced by Listeria-induccd macrophages. Science 1993; 260:547-9.
43. Hsieh C-S, Heimberger AR. Gold JS, O'Garra A, Murphy KM. Diffential regulation of T helper phenotype development by IL-4 and 10 in an αβ T cell-receptor transgenic system, Proc Natl Acad Sci USA 1992; R9;6065-9.
44. + T cells from T cell receptor transgenic mice, J Exp Med 1992; 176:1091-8.
45. Varkila K, Chatalain R, Leal LM, Coffman RL. Reconstitution of C.B-17 scid mice with BALB/c T cells initiates a T helper type-1 response and renders them capable of healing Leishmania, major infection. Eur J Immunol 1993; 23:262-8.
46. + B lymphocytes. Int Immunol 1990; 2:515-20.